ArticleInternational journal of general medicine2026

Integrating Bioinformatics and Experimental Validation Identify CCNA2 as a Novel Prognostic Biomarker and Tumor Promoter via the PI3K/AKT Pathway in Lung Adenocarcinoma.

Jian-Ping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.